Severe rhabdomyolysis induced by a retard formulation of bezafibrate in a CAPD patient.
Panuccio
V
V
Enia
G
G
Parlongo
S
S
Cutrupi
S
S
Zoccali
C
C
D001629:Bezafibrate / Q000008:administration & dosage / Q000009:adverse effects*; D003692:Delayed-Action Preparations; D005260:Female; D006801:Humans; D000960:Hypolipidemic Agents / Q000008:administration & dosage / Q000009:adverse effects*; D008875:Middle Aged; D010531:Peritoneal Dialysis, Continuous Ambulatory / Q000009:adverse effects*; D007690:Polycystic Kidney Diseases / Q000150:complications / Q000628:therapy; D012206:Rhabdomyolysis / Q000139:chemically induced*
D003692:Delayed-Action Preparations; D000960:Hypolipidemic Agents; D001629:Bezafibrate